Breaking News

One 2 One Appoints General Manager

July 17, 2013

Blair brings more than 30 years of experience

Karen Blair has joined Hospira Inc. as general manager to lead One 2 One™, Hospira’s contract development and manufacturing services business. Mrs. Blair will be responsible for overall P&L accountability, sales, marketing, business development, and customer relationship management. She will also lead the One 2 One™ team, which includes operations, R&D, program management and other functions, to ensure the overall success of One 2 One™ business.
Mrs. Blair brings more than 30 years of experience across a broad spectrum of pharmaceutical marketing and general management roles as well as in contract manufacturing. She spent most of her career with Baxter Healthcare in roles of increasing responsibility in marketing, sales and general management, including holding the position of vice president / general manager of Baxter BioPharma Solutions. During her time at Baxter, she drove substantial growth of the contract manufacturing services business and promoted a culture of customer service excellence.
Karen Blair said, “I am very excited about the opportunity to contribute to the success of Hospira One 2 One™. For quite some time I had been observing One 2 One™ as one of the major competitors and now I will be helping to shape its future. The strength of this business, expertise in parenteral product manufacturing, is truly substantial. One 2 One™ has more than 20 years of experience in addressing customer challenges and developing best practices in small molecule and biologics fill/finish technology, lyophilization, and global commercialization. I envision a great future for One 2 One™ as a preferred partner for parenteral drug manufacturing.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016